BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30324887)

  • 1. Synthesis and Biological Evaluation of Scutellarein Alkyl Derivatives as Preventing Neurodegenerative Agents with Improved Lipid Soluble Properties.
    Li HM; Gu T; Wu WY; Yu SP; Fan TY; Zhong Y; Li NG
    Med Chem; 2019; 15(7):771-780. PubMed ID: 30324887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Biological Evaluation of Scutellarein Derivatives Based on Scutellarin Metabolic Mechanism In Vivo.
    Dong ZX; Shi ZH; Li NG; Zhang W; Gu T; Zhang PX; Wu WY; Tang YP; Fang F; Xue X; Li HM; Cheng HB; Yang JP; Duan JA
    Chem Biol Drug Des; 2016 Jun; 87(6):946-57. PubMed ID: 26808289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of scutellarein derivatives to increase biological activity and water solubility.
    Shi ZH; Li NG; Shi QP; Zhang W; Dong ZX; Tang YP; Zhang PX; Gu T; Wu WY; Fang F; Xin-Xue ; Li HM; Yang JP; Duan JA
    Bioorg Med Chem; 2015 Nov; 23(21):6875-84. PubMed ID: 26455656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of methylated scutellarein analogs based on metabolic mechanism of scutellarin in vivo.
    Shi ZH; Li NG; Wang ZJ; Tang YP; Dong ZX; Zhang W; Zhang PX; Gu T; Wu WY; Yang JP; Duan JA
    Eur J Med Chem; 2015 Dec; 106():95-105. PubMed ID: 26523667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of glucose-containing scutellarein derivatives as neuroprotective agents based on metabolic mechanism of scutellarin in vivo.
    Li NG; Shen MZ; Wang ZJ; Tang YP; Shi ZH; Fu YF; Shi QP; Tang H; Duan JA
    Bioorg Med Chem Lett; 2013 Jan; 23(1):102-6. PubMed ID: 23177255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Design, synthesis and anti-oxidative evaluation of L-amino acid prodrugs of scutellarein].
    Fu XZ; Zhang W; Wang YL; Lan YY; Wang AM; Zhou W; Huang Y; Li J; Xing FJ; Liu Y
    Yao Xue Xue Bao; 2011 May; 46(5):548-55. PubMed ID: 21800542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaffold Hopping Strategy for the Design, Synthesis and Biological Activity Evaluation of Novel Hexacyclic Scutellarein Derivatives with a 1,3-Oxazine Ring Fused at A-ring.
    Zhong Y; Lu YT; Sun Y; Li NG; Gu T; Wu WY; Yu SP; Shi ZH
    Med Chem; 2018; 14(5):478-484. PubMed ID: 28875860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannich bases of scutellarein as thrombin-inhibitors: design, synthesis, biological activity and solubility.
    Li NG; Song SL; Shen MZ; Tang YP; Shi ZH; Tang H; Shi QP; Fu YF; Duan JA
    Bioorg Med Chem; 2012 Dec; 20(24):6919-23. PubMed ID: 23131413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats.
    Tang H; Tang Y; Li N; Shi Q; Guo J; Shang E; Duan JA
    Pharmacol Biochem Behav; 2014 Mar; 118():51-9. PubMed ID: 24423938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative.
    Gu T; Zhong Y; Lu YT; Sun Y; Dong ZX; Wu WY; Shi ZH; Li NG; Xue X; Fang F; Li HM; Tang YP
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28635646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and protective effect of scutellarein on focal cerebral ischemia/reperfusion in rats.
    Qian L; Shen M; Tang H; Tang Y; Zhang L; Fu Y; Shi Q; Li NG
    Molecules; 2012 Sep; 17(9):10667-74. PubMed ID: 22955455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Sang ZP; Qiang XM; Li Y; Wu B; Zhang H; Zhao MG; Deng Y
    Chem Biol Drug Des; 2015 Nov; 86(5):1168-77. PubMed ID: 25941042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Qiang X; Li Y; Yuan W; Liu Q; Shi Y; Ang W; Luo Y; Tan Z; Deng Y
    Eur J Med Chem; 2015 Apr; 94():348-66. PubMed ID: 25778991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoprotective pyridinol antioxidants as potential therapeutic agents for neurodegenerative and mitochondrial diseases.
    Alam MP; Khdour OM; Arce PM; Chen Y; Roy B; Johnson WG; Dey S; Hecht SM
    Bioorg Med Chem; 2014 Sep; 22(17):4935-47. PubMed ID: 25088548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant activity of newly synthesized 2,7-diazaphenothiazines.
    Morak-Młodawska B; Pluta K; Matralis AN; Kourounakis AP
    Arch Pharm (Weinheim); 2010 May; 343(5):268-73. PubMed ID: 20232371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties.
    Cena C; Chegaev K; Balbo S; Lazzarato L; Rolando B; Giorgis M; Marini E; Fruttero R; Gasco A
    Bioorg Med Chem; 2008 May; 16(9):5199-206. PubMed ID: 18359636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipophilic phenolic antioxidants: correlation between antioxidant profile, partition coefficients and redox properties.
    Roleira FM; Siquet C; Orrù E; Garrido EM; Garrido J; Milhazes N; Podda G; Paiva-Martins F; Reis S; Carvalho RA; Silva EJ; Borges F
    Bioorg Med Chem; 2010 Aug; 18(16):5816-25. PubMed ID: 20650639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants.
    Sanmartín-Suárez C; Soto-Otero R; Sánchez-Sellero I; Méndez-Álvarez E
    J Pharmacol Toxicol Methods; 2011; 63(2):209-15. PubMed ID: 21059397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why Have Clinical Trials of Antioxidants to Prevent Neurodegeneration Failed? - A Cellular Investigation of Novel Phenothiazine-Type Antioxidants Reveals Competing Objectives for Pharmaceutical Neuroprotection.
    Ohlow MJ; Sohre S; Granold M; Schreckenberger M; Moosmann B
    Pharm Res; 2017 Feb; 34(2):378-393. PubMed ID: 27896592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity.
    Guo H; Hu LM; Wang SX; Wang YL; Shi F; Li H; Liu Y; Kang LY; Gao XM
    Chin J Physiol; 2011 Dec; 54(6):399-405. PubMed ID: 22229507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.